During a heart attack, irreparable damage is done to the heart muscle as a result of defective circulation. The feared consequence is what is known as ventricular tachycardias and the ventricular fibrillation that results from that. In this case, the hollow muscle's contraction is not coordinated and contracts at a high pulse rate. The frequency can reach more than 300 beats per minute. This condition is life-threatening because the blood cannot be pumped effectively via the blood circulation.
By implanting embryonic myocardial cells, this risk can apparently be drastically reduced, at least in mice. These are the results of scientists from the universities of Bonn, Cornell and Pittsburgh, published in the journal 'Nature'. The scientists treated mice after a heart attack with these cells and then tried to cause ventricular tachycardias by means of electrical stimulation. Only with slightly over one third of the mice did this arrhythmia occur just as rarely as with thoroughly healthy rodents. By contrast, with untreated mice after a heart attack this ratio was almost 100 per cent.
A few thousand cells are sufficient
Replacing the dead heart tissue with new muscle cells is not a completely new idea. Up to now, the doctors focused especially on the reconstruction of the muscular function. After all, several hundred million muscle cells perish during a heart attack. The result is often heart failure, which can also be fatal. 'This weakness of the cardiac muscle cannot be resolved with spare tissue, even today,' Professor Bernd K. Fleischmann from the Institute of Physiology 1 explains. 'Too few implanted cells actually take on a permanent muscular function. For the prevention of cardiac arrhythmia, even a few thousand cells seem to be sufficient.'
With the skeletal muscular cells which were used for the therapy up to now, that actually does not work. 'They do not reduce the risk of a ventricular tachycardia. The opposite is true: the severity of the cardiac arrhythmia even increased in our study when we used skeletal muscular cells,' the Bonn cardiologist Professor Thorsten Lewalter emphasises. The reason for this is that for an ordered contraction it is important that the cells in the heart muscle communicate with another. To a certain extent, they pass on the 'pulse signal' to their neighbours for this. 'Real' heart muscle cells naturally have a special information channel for this purpose. We're talking about a cellular protein called Connexin 43. 'We were able to show that the embryonic myocardial cells which we implanted synthesise this protein Connexin 43, thereby allowing the electrical signal to be coupled into the infarction scar,' the heart surgeon Dr. Wilhelm Röll and physiologist Dr. Phillip Sasse explain.
New therapeutic approach
Scientists from the Institute of Genetics were successful in changing skeletal muscular cells in such a way that they also produced Connexin 43. The researchers also successfully tested these cells on mice that had had a heart attack. The risk level of a ventricular tachycardia fell to a level similar to that in healthy animals. This discovery potentially opens the door to a completely new therapeutic approach. With humans it is nevertheless not possible, for ethical reasons, to make use of embryonic heart muscle cells. 'But you could use stem cells from the leg muscle of a heart attack patient and install the gene for Connexin 43 in them,' says Professor Michael I. Kotlikoff from Cornell University in Ithaca. 'These modified cells could be then implanted in the damaged heart.' Rejection of the cells is unlikely in this case since the body would be dealing with its own (albeit genetically upgraded) cells. Bernd Fleischmann also talks about an important intermediate stage but urges caution about inflated hopes. 'Our results are valid for mice hearts,' he clarifies. 'Whether it works this way with humans has yet to be seen.'
The fact that the study was so successful was also due to the interdisciplinary nature of the project. With the Institute of Physiology 1 at the Life&Brain Centre, the Departments of Cardiosurgery and Internal Medicine II, as well as the Institutes of Genetics and Pharmacology, five research groups were involved in Bonn alone.
Prof. Dr. Bernd K. Fleischmann | alfa
Biologists unravel another mystery of what makes DNA go 'loopy'
16.03.2018 | Emory Health Sciences
Scientists map the portal to the cell's nucleus
16.03.2018 | Rockefeller University
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...
16.03.2018 | Event News
13.03.2018 | Event News
08.03.2018 | Event News
16.03.2018 | Earth Sciences
16.03.2018 | Physics and Astronomy
16.03.2018 | Life Sciences